Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Compound inhibits acute myeloid leukemia cells with FLT3-ITD mutations by targeting HSP70

Oct. 1, 2021

GlaxoSmithKline compounds may illuminate TAF1 (BD2) potential as a therapeutic target

Sep. 30, 2021

ER-001259851-000, novel selective Axl inhibitor with promising PK profile in vivo

Sep. 30, 2021

New CDK12 inhibitors presented by Bayer, Deutsches Krebsforschungszentrum

Sep. 30, 2021

Ennovabio, Shanghai Ennova Biopharmaceutical patent MAP4K1 inhibitors

Sep. 30, 2021

Sironax describes new ferroptosis inhibitors

Sep. 30, 2021

Restored ciliogenesis switches glioma stem cells from self-renewal to differentiation

Sep. 30, 2021

Point Biopharma reports preclinical data on FAP-alpha inhibitor program

Sep. 29, 2021

RARA identified as a druggable target for pediatric acute myeloid leukemia

Sep. 29, 2021

New KDM1A inhibitors discovered at Shenyang Pharmaceutical University

Sep. 29, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...